Evidence map›Paper›PMID 39606495›Full record

ArticleCureus2024

Pancreatic Leiomyosarcoma With Multi-organ Metastases: A Rare Case.

Safia Alnaqbi, Pawan Kumar, Abdulrahman Bin Sumaida, Nandan M Shanbhag, Amna Z Ahmad, Khalid Balaraj

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Safia AlnaqbiOncology, Tawam Hospital, Al Ain, ARE.
Pawan KumarOncology, Tawam Hospital, Al Ain, ARE.
Abdulrahman Bin SumaidaOncology/Radiation Oncology, Tawam Hospital, Al Ain, ARE.
Nandan M ShanbhagInternal Medicine, College of Health Sciences, United Arab Emirates University, Al Ain, ARE.
Amna Z AhmadPathology, PureLab, Abu Dhabi, ARE.
Khalid BalarajOncology/Radiation Oncology, Tawam Hospital, Al Ain, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes the diagnosis, treatment, and progression of a 50-year-old male patient diagnosed with stage IV pancreatic leiomyosarcoma with metastases to the liver, lungs, and brain, representing the only case involving both the pancreas and brain documented in the hospital registry with a histopathological diagnosis of leiomyosarcoma. The patient initially presented with chronic abdominal pain, constipation, and weight loss, and subsequent CT scans revealed a large pancreatic mass with metastases to the liver, lungs, and brain. A biopsy confirmed the diagnosis of leiomyosarcoma, and the patient underwent eight cycles of palliative chemotherapy with cisplatin and docetaxel, along with palliative radiotherapy targeting the brain metastases. Despite these interventions, the disease progressed, resulting in the patient experiencing altered mental status, generalized weakness, and seizure-like activity, reflecting the impact of the brain metastases and overall disease progression. His management included treatment with dexamethasone, antiseizure medications, and supportive care, while discussions about palliative care options were conducted with the family. This rare case highlights the aggressive nature of pancreatic leiomyosarcoma, characterized by rapid progression and resistance to chemotherapy and radiotherapy, with the involvement of multiple organ systems demonstrating the challenges associated with managing advanced metastatic leiomyosarcoma.

Indexed as

advanced sarcoma managementaggressive malignancybrain metastasesmetastatic cancermultidisciplinary oncologypalliative chemotherapypalliative radiotherapypancreatic leiomyosarcomatumor pathophysiology

Identifiers

PMID39606495
PMCPMC11600098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.